🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This drug-drug interaction study will evaluate the impact of two different ...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2017-09-21
Trial ID
NCT03302845
Treatments Being Tested
Aspirin and clopidogrel +/- heparin or thrombolytic co-therapy is well esta...
Status
Completed
Location
Ruttonjee Hospital
Start Date
2008-07
Trial ID
NCT00683111
Treatments Being Tested
This randomized, open-label, single-centre controlled study evaluates the e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07539961
Treatments Being Tested
Stroke is the 4th leading cause of death in United States with an estimated...
Status
Completed
Location
Shands Hospital at University of Florida
Start Date
2014-12
Trial ID
NCT02142712
Treatments Being Tested
The purpose of this study is to determine the safest dose of the multiple R...
Status
Completed
Location
Premiere Oncology of Arizona
Start Date
2007-02
Trial ID
NCT00451880
Treatments Being Tested
This research is to determine which medication, Zegerid (Omeprazole/Sodium ...
Status
Completed
Location
University of Missouri Health Care
Start Date
2006-11
Trial ID
NCT00557349
Treatments Being Tested
This is a two-part multi-center clinical trial in participants with active ...
Status
Terminated
Location
Emory Healthcare
Start Date
2021-10-13
Trial ID
NCT04918147
This study will be conducted to evaluate the effect of lemborexant 10 milli...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2018-02-05
Trial ID
NCT03451110
Treatments Being Tested
Background: Hairy cell leukemia (HCL) is a rare, slow-growing blood cancer...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-10-03
Trial ID
NCT03805932
This is a Phase 1, Open-Label, Adaptive Study of Novel GS-9973 Tablet Formu...
Status
Completed
Location
Investigational Site
Start Date
2013-05
Trial ID
NCT01841489